Genomics and post-genomics of Staphylococcus aureus causing bullous impetigo
Genomics and post-genomics of Staphylococcus aureus causing bullous impetigo
批准号:
15390143
负责人:
SUGAI Motoyuki
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
在本研究中,我们与日本60多家全国性医院和开放诊所合作,采集了大疱性脓疱病患者皮损的细菌标本,并在本实验室进行了金黄色葡萄球菌的分离。我们鉴定了1017株金黄色葡萄球菌。对分离的菌株进行SmaI酶切、Eta、ETB、ETD基因Southern杂交、凝固酶试验、SEA、SEB、SEC、SED凝集试验、ETA、ETB、ETD、SEA、SEB、Sec、Se、tsst-1、FEMA、mecA的聚合酶链式反应检测。用凝胶比较法对分离菌株的全部PFGE图谱进行了聚类分析。同时测定分离菌株对头孢菌素、大环内酯类、呋喃西酸、四环素、喹诺酮类药物的MIC。根据这些特征,我们发现引起日本大疱性脓疱病的菌株被聚为五个克隆群,它们的脱落毒素产量、凝固酶类型与聚类结果很好地相关,即有三个产生ETA的簇,一个产生ETB的簇和一个产生ETD的簇。三个产生ETA的簇分别是凝固酶V、III和VI型。ETB产生簇为I型,ETD产生簇为II型。令人惊讶的是,凝固酶III型ETA产生簇100%为mecA阳性,70%ETB产生簇为mecA阳性。多位点测序结果与聚类分析结果具有很好的相关性,表明它们具有克隆性。MIC检测清楚地表明,这些mecA阳性菌株对β-内酰胺类药物具有临界水平的耐药性。这些结果强烈表明,在日本,现在引起大疱性脓疱病的TEO克隆群正在扩大为MRSA。
英文摘要
In this study, we collected bacterial specimens by seed swab from lesions of bullous impetigo patients with the cooperation of more than 60 nation-wide hospitals and open clinics in Japan and isolated Staphylococcus aureus in our laboratory. We identified 1,017 S.aureus strains. The isolated strains were subjected to PFGE by SmaI digestion, Southern hybridization for genes of eta,etb,etd, coagulase testing, agglutination test for SEA,SEB,SEC,SED,PCR testing for eta,etb, etd,sea, seb,sec,sed,tsst-1,femA,mecA. The overaII PFGE patterns of isolated strains weresubjected to clustering analysis by Gel Compar. Isolated strains were also subjected for measurement of MIC against cefem, macrolide, fusigic acid, tetracycline, quinolone. Upon these characterization, we discovered that strains causing bullous impetigo in Japan were clustered in five clonal groups and their producibility of exfoliative toxin, coagulase types well correlated with clustering results, i.e.there are three ETA-producing clusters, one ETB-producing and one ETD-producing clusters. Three ETA-producing clusters are coagulase type V,III, and VII respectively. ETB-producing cluster is type I and ETD-producing cluster is type II. Surprisingly, 100% of coagulase type III ETA-producing cluster is mecA positive and 70% of ETB-producing cluster is mecA positive. Multilocus sequencing results well correlated with clustering analysis indicating their clonality. MIC testing clearly indicated that those mecA positive strains are borderline level resistant to β-lactams. These results strongly suggested that in Japan now teo clonal groups causing bullous impetigo are expanding as MRSA.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/j.1365-2958.2004.04200.x
发表时间:
2004-08-01
期刊:
MOLECULAR MICROBIOLOGY
影响因子:
3.6
作者:
[Komatsuzawa, H, Fujiwara, T, Sugai, M]
通讯作者:
Sugai, M
Bullous impetigo and Staphylococcus aureus
大疱性脓疱病和金黄色葡萄球菌
DOI:
--
发表时间:
2005
期刊:
Antibiotics and chemotherapy vo1.21 No.3
影响因子:
--
作者:
[Motoyuki Sugai, Takayuki Yamaguchi]
通讯作者:
Takayuki Yamaguchi
MRSA is increasing in S.aureus causing bullous impetigo.
MRSA 在金黄色葡萄球菌中增加,导致大疱性脓疱病。
DOI:
--
发表时间:
2003
期刊:
Current Topics No.55
影响因子:
--
作者:
[Someya K et al., Motoyuki Sugai]
通讯作者:
Motoyuki Sugai
DOI:
10.1128/jb.187.2.480-487.2005
发表时间:
2005-01-01
期刊:
JOURNAL OF BACTERIOLOGY
影响因子:
3.2
作者:
[Fujiwara, T, Aoki, S, Sugai, M]
通讯作者:
Sugai, M
Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in staphylococcus aureus
金黄色葡萄球菌对默诺霉素的耐药性与万古霉素的中度敏感性有关
DOI:
--
发表时间:
2003
期刊:
Microbiology and Immunology 47
影响因子:
--
作者:
[Hiromi Nishi et al.]
通讯作者:
Hiromi Nishi et al.
共 15 条
Intranuclear action of Cell cycle-specific growth inhibitory factor, CDT
-
批准号:20592140
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:SUGAI Motoyuki
-
依托单位:
Integrated Research on pathogenic factors of periodontal pathogens
-
批准号:17591912
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:SUGAI Motoyuki
-
依托单位:
Genome-wide study on pathogenesis of bacteria causing nosocomial infection
-
批准号:17019048
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$62.4万
-
财政年份:2005
-
负责人:SUGAI Motoyuki
-
依托单位:
A study on the function of cell-cycle specific inhibitor, CDT
-
批准号:12470064
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2000
-
负责人:SUGAI Motoyuki
-
依托单位:
MECHANISM OF ACTION OF CYTOTOXIC NECROTIZING FACTOR(CNF)PRODUCED BY PATHOGENIC ESCHERICHIA COLI
-
批准号:09670282
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:SUGAI Motoyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢颖
-
依托单位:
野菊花内生真菌中抗MRSA活性成分及其作用机制
-
批准号:JCZRLH202601040
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
-
批准号:2026JJ30179
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:伍勇
-
依托单位:
靶向新航向:STAT3抑制剂对MRSA的抗菌作用及其分子机制研究
-
批准号:2026JJ50552
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴苑
-
依托单位:
基于天然产物吴茱萸次碱的抗MRSA先导发现、结构优化及机制研究
-
批准号:2026JJ50341
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨瑞阁
-
依托单位:
黎药红葱中靶向sarA蛋白抗MRSA生物被膜活性萘醌类成分及其作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈德力
-
依托单位:
基于中性粒细胞活化探讨食源性酿酒酵母葡聚糖SG90抗MRSA感染的免疫机制研究
-
批准号:JCZRLH202600868
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
新型抗MRSA先导化合物作用靶标PflB的确证及抗菌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程琦
-
依托单位:
基于基因组溯源方法体系阐明MRSA跨种
属传播机制和风险
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:叶小华
-
依托单位:
两株黄连内生真菌抗MRSA活性成分的发现及作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:尹国平
-
依托单位: